CN109641059B - 具有改善的防腐效力或光稳定性的眼科药物组合物 - Google Patents

具有改善的防腐效力或光稳定性的眼科药物组合物 Download PDF

Info

Publication number
CN109641059B
CN109641059B CN201780049806.1A CN201780049806A CN109641059B CN 109641059 B CN109641059 B CN 109641059B CN 201780049806 A CN201780049806 A CN 201780049806A CN 109641059 B CN109641059 B CN 109641059B
Authority
CN
China
Prior art keywords
carteolol
pharmaceutically acceptable
acceptable salt
appropriate amount
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201780049806.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN109641059A (zh
Inventor
长滨良治
近藤文雄
大八木优
平田雄树
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to CN202211127527.1A priority Critical patent/CN115444849B/zh
Priority to CN202211126345.2A priority patent/CN115463130A/zh
Publication of CN109641059A publication Critical patent/CN109641059A/zh
Application granted granted Critical
Publication of CN109641059B publication Critical patent/CN109641059B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201780049806.1A 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物 Active CN109641059B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202211127527.1A CN115444849B (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物
CN202211126345.2A CN115463130A (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016-162611 2016-08-23
JP2016162611 2016-08-23
PCT/JP2017/029934 WO2018038102A1 (en) 2016-08-23 2017-08-22 Ophthalmic pharmaceutical composition with improved preservative effectiveness or light stability

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN202211126345.2A Division CN115463130A (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物
CN202211127527.1A Division CN115444849B (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物

Publications (2)

Publication Number Publication Date
CN109641059A CN109641059A (zh) 2019-04-16
CN109641059B true CN109641059B (zh) 2022-08-30

Family

ID=59812062

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201780049806.1A Active CN109641059B (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物
CN202211127527.1A Active CN115444849B (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物
CN202211126345.2A Pending CN115463130A (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN202211127527.1A Active CN115444849B (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物
CN202211126345.2A Pending CN115463130A (zh) 2016-08-23 2017-08-22 具有改善的防腐效力或光稳定性的眼科药物组合物

Country Status (4)

Country Link
JP (4) JP7123034B2 (https=)
CN (3) CN109641059B (https=)
TW (4) TWI828025B (https=)
WO (1) WO2018038102A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022131565A (ja) * 2021-02-26 2022-09-07 ロート製薬株式会社 水性医薬組成物
CN114788809B (zh) * 2022-01-25 2023-04-14 江苏广承药业有限公司 一种氯雷他定液体制剂

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1836667A (zh) * 2005-03-22 2006-09-27 帝化制药株式会社 滴眼剂
CN1939277A (zh) * 2005-09-30 2007-04-04 庄臣及庄臣视力保护公司 稳定眼用组合物的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01135887A (ja) * 1987-11-20 1989-05-29 Lion Corp 紫外線吸収剤組成物
FR2777189B1 (fr) * 1998-04-09 2001-04-06 Chauvin Lab Sa Composition ophtalmique comprenant un beta-bloquant
JP4361294B2 (ja) 2003-02-25 2009-11-11 ロート製薬株式会社 ケトチフェン含有組成物
JP5711957B2 (ja) 2003-09-30 2015-05-07 ロート製薬株式会社 透明包装体入りトラニラスト含有医薬製剤
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur
US8673937B2 (en) * 2008-04-23 2014-03-18 Otsuka Pharmaceutical Co., Ltd. Eye-drop preparation and use thereof
CN101461780A (zh) 2009-01-06 2009-06-24 河北科技大学 不含抑菌剂的盐酸卡替洛尔滴眼液及其制备方法
TW201109325A (en) 2009-07-30 2011-03-16 Wakamoto Pharma Co Ltd Aqueous composition for eye drops
US20130149394A1 (en) * 2010-08-27 2013-06-13 Wakamoto Pharmaceutical Co., Ltd. Aqueous ophthalmic composition
JP5345743B1 (ja) * 2012-02-27 2013-11-20 ロート製薬株式会社 眼科用組成物キット

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1836667A (zh) * 2005-03-22 2006-09-27 帝化制药株式会社 滴眼剂
CN1939277A (zh) * 2005-09-30 2007-04-04 庄臣及庄臣视力保护公司 稳定眼用组合物的方法

Also Published As

Publication number Publication date
JP2026021353A (ja) 2026-02-10
CN109641059A (zh) 2019-04-16
TW202231276A (zh) 2022-08-16
CN115444849A (zh) 2022-12-09
TW202513068A (zh) 2025-04-01
WO2018038102A1 (en) 2018-03-01
TWI828025B (zh) 2024-01-01
TWI814709B (zh) 2023-09-11
JP2019526549A (ja) 2019-09-19
JP7123034B2 (ja) 2022-08-22
CN115463130A (zh) 2022-12-13
JP2022172124A (ja) 2022-11-15
CN115444849B (zh) 2025-07-01
JP2024112862A (ja) 2024-08-21
TW202332446A (zh) 2023-08-16
TW201811331A (zh) 2018-04-01

Similar Documents

Publication Publication Date Title
JP2021035984A (ja) ポビドンヨード、眼科用組成物のための新規代替保存剤
JP6441087B2 (ja) ピリジルアミノ酢酸化合物含有医薬組成物
KR102491425B1 (ko) 에피나스틴 함유 점안액
JP2026021353A (ja) 保存効力又は光安定性が改善された点眼用医薬組成物
RU2745317C2 (ru) Фармацевтическая композиция, включающая дорзоламид и бримонидин
US9561280B2 (en) Aqueous liquid bromfenac composition having preservative efficacy
HK40082706A (zh) 具有改善的防腐效力或光稳定性的眼科药物组合物
HK40082707A (en) Ophthalmic pharmaceutical composition with improved preservative effectiveness or light stability
HK40082706B (zh) 具有改善的防腐效力或光稳定性的眼科药物组合物
RU2675813C2 (ru) Эмульсионная композиция дифлупредната, содержащая цинк
JP2017066033A (ja) 水性医薬組成物
JP6050454B1 (ja) 水性医薬組成物
RU2745617C2 (ru) Антисептическое средство, включающее меглюмин или его соль
CN102497854A (zh) 含有作为防腐剂的丙酸衍生物的眼用液体药物组合物
RU2776062C2 (ru) Жидкая композиция с бромфенаком на водной основе, обладающая консервирующей эффективностью
JP2025147067A (ja) 水性医薬組成物
WO2024135837A1 (ja) 組織移行性及び防腐効力を向上させるエピナスチン含有水性組成物
TW202404569A (zh) 含有賽佩普斯特(Sepetaprost)之眼科用組合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant